AX-158 has achieved clinical validation through its phase 2a trial for the treatment of patients with mild to moderate plaque ...

The following is a summary of “Bimekizumab efficacy and safety through 3 years in patients with moderate to severe plaque ...

Knowing which kind of psoriasis ... plaque psoriasis. If you have psoriasis under your arms, aka inverse psoriasis, you might wonder if it’s OK to use deodorant or antiperspirant. Scalp ...

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

Higher cardiovascular health scores on Life’s Essential 8 were linked to a significantly lower risk for psoriasis in a large, ...

Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the population and is mediated ...

Having psoriasis, an autoimmune condition that causes inflamed skin patches, can make you more likely to develop certain skin infections. A combination of factors—such as a damaged skin barrier ...

The usual Bryhali (halobetasol) dosage for plaque psoriasis is a thin layer applied to the affected area of skin once per day. It’s important to use the dosage of Bryhali your doctor prescribes.

A doctor may prescribe injectable treatments, such as methotrexate, TNF-alpha inhibitors, or interleukin inhibitors, for moderate to severe psoriasis when other treatments don’t work.

J&J is hoping to show that the peptide drug can be a more patient-friendly alternative to injectable biologics for plaque psoriasis, including drugs working on IL-23, such as J&J's own Tremfya ...